De novo childhood myelodysplastic/myeloproliferative disease with unique molecular characteristics

1 Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study British Journal of Cancer, May 6, 2013

2 Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM) Leukemia Research, May 9, 2013

3 Border between aplastic anemia and myelodysplastic syndrome International Journal of Hematology, May 8, 2013

4 Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia Hematology, May 7, 2013

5 Communicating syringomyelia associated with ventriculoperitoneal shunt malfunction verified with a cerebrospinal fluid dynamic study: case report Child's Nervous System, May 14, 2013

6 Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML New England Journal of Medicine, May 13, 2013    Evidence Based Medicine

7 The changing mutational landscape of acute myeloid leukemia and myelodysplastic syndrome Molecular Cancer Research, May 10, 2013    Review Article

8 Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability Annals of Hematology, May 7, 2013

9 Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia Hematology, May 17, 2013

10 The Evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes Hematology, May 15, 2013